Q3 results, Rs 42.7 cr warrant conversion, MD re-appointment
LORDSCHLO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.9 pts less than Nifty Microcap 250 and 6.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q3 FY26 revenue grew 43 percent YoY to Rs 93.95 cr, PAT jumped to Rs 4.61 cr from Rs 1.27 cr. 9M FY26 revenue at Rs 292.49 cr (up 54 percent), PAT at Rs 24.07 cr versus Rs 3.58 cr. Board allotted 35 lakh shares at Rs 122 each (Rs 42.7 cr) on warrant conversion to promoter and non-promoter groups. Promoter holding rose from 74.66 to 74.97 percent. MD Ajay Virmani re-appointed for 5 years from July 2026. EGM set for March 18, 2026.
Strong revenue and profit growth with limited equity dilution. Promoter stake rises. Positive momentum, but watch for ESOP dilution later.